Back
Blueprint Medicines Stock Price Chart
This New Idea is Set to Shock the World
Click here to learn all the details.
Sell
46
BPMC
Blueprint Medicines
Last Price:
111.72
Seasonality Move:
10.58%
7 Day Trial
ALL ACCESS PASS
$
7
7 Stocks to Own Before the 2024 Election
Click the link below to get your copy. FREE- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BPMC is experiencing buying pressure, which is a positive indicator for future bullish movement.
Blueprint Medicines Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 108.39 | Buy |
| 20-day SMA: | 106.42 | Buy |
| 50-day SMA: | 104.24 | Buy |
| 200-day SMA: | 82.56 | Buy |
| 8-day EMA: | 108.84 | Buy |
| 20-day EMA: | 106.94 | Buy |
| 50-day EMA: | 103.3 | Buy |
| 200-day EMA: | 86.56 | Buy |
Blueprint Medicines Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.81 | Buy |
| Relative Strength Index (14 RSI): | 62.72 | Buy |
| Chaikin Money Flow: | 288658 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (103.88 - 108.36) | Buy |
| Bollinger Bands (100): | (88.28 - 105.64) | Buy |
Blueprint Medicines Technical Analysis
| Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | Jul 2 | Jul 3 | Jul 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | Jul | |||||||||
| 21 | 24 | 25 | 26 | 27 | 28 | 01 | 02 | 03 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Blueprint Medicines Stock
Is Blueprint Medicines Stock a Buy?
- Blueprint Medicines share price is 111.70 while BPMC 8-day simple moving average is 108.39, which is a Buy signal.
- The stock price of BPMC is 111.70 while Blueprint Medicines 20-day SMA is 106.42, which makes it a Buy.
- Blueprint Medicines 50-day simple moving average is 104.24 while BPMC share price is 111.70, making it a Buy technically.
- BPMC stock price is 111.70 and Blueprint Medicines 200-day simple moving average is 82.56, creating a Buy signal.
BPMC Technical Analysis vs Fundamental Analysis
Sell
46
Blueprint Medicines (BPMC)
is a Sell
Is Blueprint Medicines a Buy or a Sell?
-
Blueprint Medicines stock is rated a Sell
The current Blueprint Medicines [BPMC] share price is $111.70. The Score for BPMC is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
Blueprint Medicines Stock Info
Market Cap:
6.99B
Price in USD:
111.70
Share Volume:
343.02K
Blueprint Medicines 52-Week Range
52-Week High:
111.99
52-Week Low:
43.89
Sell
46
Blueprint Medicines (BPMC)
is a Sell
Blueprint Medicines Share Price Forecast
-
What is the Blueprint Medicines stock price today?
The Blueprint Medicines stock price is 111.70 USD today. -
Will BPMC stock go up or go down?
Blueprint Medicines> share price is forecast to RISE/FALL based on technical indicators -
Is Blueprint Medicines overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Blueprint Medicines is overvalued.
Is Blueprint Medicines Stock a Buy?
- Blueprint Medicines share price is 111.70 while BPMC 8-day exponential moving average is 108.84, which is a Buy signal.
- The stock price of BPMC is 111.70 while Blueprint Medicines 20-day EMA is 106.94, which makes it a Buy.
- Blueprint Medicines 50-day exponential moving average is 103.30 while BPMC share price is 111.70, making it a Buy technically.
- BPMC stock price is 111.70 and Blueprint Medicines 200-day simple moving average is 86.56, creating a Buy signal.
Fundamental Analysis of Blueprint Medicines
Is Blueprint Medicines a good investment?
- Analysts estimate an earnings increase this quarter of $1.17 per share, an increase next quarter of $0.33 per share, an increase this year of $5.90 per share, and an increase next year of $0.62 per share.
Technical Analysis of Blueprint Medicines
Should I short Blueprint Medicines stock?
- BPMC Moving Average Covergence Divergence (MACD) indicator is 1.81, suggesting Blueprint Medicines is a Buy
- Blueprint Medicines Relative Strength Index (RSI) is 62.72, which suggest Blueprint Medicines is overbought
- The Bollinger Bands (25) for Blueprint Medicines is (103.88 - 108.36), which suggest Blueprint Medicines is a Buy
- The Bollinger Bands (100) for Blueprint Medicines is (88.28 - 105.64), which suggest Blueprint Medicines is a Buy
* Blueprint Medicines stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.